Liora Life Sciences, LLC

New Filing
CIK: 0002157034·Other Health Care·DELAWARE·Filed: Oct 1, 2026
Total Offering

$640,625,000

Amount Sold

$300,000

Investors

2

First Sale

Sep 14, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(c)
Entity Type
Limited Liability Company
Year Incorporated
2025
Non-Accredited Investors
No

Related Persons

NameRole
William Tanenbaum
Related Person
Liora MGMT, LLC
Related Person

Company

Liora Life Sciences, LLC

9561 SOUTH 700 EAST, SUITE 202

SANDY, UT, 84070

801-565-0502

SEC Filing

0002157034-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free